SHZ:300122

Chongqing Zhifei Biological Products Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:28 UTC

Last close

n/aCNY

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
-57.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-164.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
50.8%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.78Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
1.0%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

Growth is the furthest below its sector's middle: 0.05 against 0.50 on the market's range.

All from 100

lens 2 of 9

Sales

2,009

2016-12-31 to 2025-12-31100 at the start2,009

Sales: 100.00 on 2016-12-31 to 2008.86 on 2025-12-31, up 1909%.

Profit

-45,274

2016-12-31 to 2025-12-31100 at the start-45,274

Profit: 100.00 on 2016-12-31 to -45273.71 on 2025-12-31, down 45374%.

Shares in issue

154

2016-12-31 to 2025-12-31100 at the start154

Shares in issue: 100.00 on 2016-12-31 to 154.08 on 2025-12-31, up 54%.

Sales is at 2009, Profit is at -45274, Shares in issue is at 154, against 100 in 2016.

Sales is at 2009, Profit is at -45274, Shares in issue is at 154, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 1002,009
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 100-45,274
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 100154
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY